458 related articles for article (PubMed ID: 11774948)
1. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
Metge CJ; Blanchard JF; Peterson S; Bernstein CN
Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948
[TBL] [Abstract][Full Text] [Related]
2. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
[TBL] [Abstract][Full Text] [Related]
3. The relationship between inflammatory bowel disease and socioeconomic variables.
Bernstein CN; Kraut A; Blanchard JF; Rawsthorne P; Yu N; Walld R
Am J Gastroenterol; 2001 Jul; 96(7):2117-25. PubMed ID: 11467642
[TBL] [Abstract][Full Text] [Related]
4. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
[TBL] [Abstract][Full Text] [Related]
5. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
6. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
7. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
[TBL] [Abstract][Full Text] [Related]
8. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Kreisel W; Wolf LM; Grotz W; Grieshaber M
Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
[TBL] [Abstract][Full Text] [Related]
9. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis.
Longobardi T; Jacobs P; Bernstein CN
Am J Gastroenterol; 2004 Apr; 99(4):650-5. PubMed ID: 15089897
[TBL] [Abstract][Full Text] [Related]
10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
12. Association between spring season of birth and Crohn's disease.
Shaw SY; Nugent Z; Targownik LE; Singh H; Blanchard JF; Bernstein CN
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):277-82. PubMed ID: 23924874
[TBL] [Abstract][Full Text] [Related]
13. Generational differences in the age at diagnosis with Ibd: genetic anticipation, bias, or temporal effects.
Faybush EM; Blanchard JF; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2002 Mar; 97(3):636-40. PubMed ID: 11922559
[TBL] [Abstract][Full Text] [Related]
14. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
15. Seeking prescribing patterns in rural Crete: a pharmacoepidemiological study from a primary care area.
Antonakis N; Xylouri I; Alexandrakis M; Cavoura C; Lionis C
Rural Remote Health; 2006; 6(1):488. PubMed ID: 16464135
[TBL] [Abstract][Full Text] [Related]
16. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.
Bernstein CN; Nugent Z; Longobardi T; Blanchard JF
Am J Gastroenterol; 2009 Nov; 104(11):2774-8. PubMed ID: 19623167
[TBL] [Abstract][Full Text] [Related]
17. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.
Shaw SY; Blanchard JF; Bernstein CN
Am J Gastroenterol; 2011 Dec; 106(12):2133-42. PubMed ID: 21912437
[TBL] [Abstract][Full Text] [Related]
18. Management of inflammatory bowel disease during pregnancy and nursing.
Friedman S
Semin Gastrointest Dis; 2001 Oct; 12(4):245-52. PubMed ID: 11726078
[TBL] [Abstract][Full Text] [Related]
19. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
[TBL] [Abstract][Full Text] [Related]
20. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]